Dimensional Fund Advisors LP lifted its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 10.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 783,038 shares of the medical equipment provider’s stock after acquiring an additional 72,721 shares during the quarter. Dimensional Fund Advisors LP owned 0.39% of Zimmer Biomet Holdings worth $100,539,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ZBH. Enterprise Financial Services Corp raised its position in shares of Zimmer Biomet Holdings by 0.3% during the second quarter. Enterprise Financial Services Corp now owns 2,646 shares of the medical equipment provider’s stock worth $340,000 after purchasing an additional 9 shares during the period. Sandy Spring Bank lifted its holdings in shares of Zimmer Biomet Holdings by 1.7% during the first quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock valued at $149,000 after purchasing an additional 20 shares during the last quarter. Cleararc Capital Inc. lifted its holdings in shares of Zimmer Biomet Holdings by 0.5% during the first quarter. Cleararc Capital Inc. now owns 4,897 shares of the medical equipment provider’s stock valued at $598,000 after purchasing an additional 25 shares during the last quarter. Parkside Financial Bank & Trust lifted its holdings in shares of Zimmer Biomet Holdings by 3.9% during the second quarter. Parkside Financial Bank & Trust now owns 872 shares of the medical equipment provider’s stock valued at $112,000 after purchasing an additional 33 shares during the last quarter. Finally, CWA Asset Management Group LLC lifted its holdings in shares of Zimmer Biomet Holdings by 1.8% during the second quarter. CWA Asset Management Group LLC now owns 1,952 shares of the medical equipment provider’s stock valued at $251,000 after purchasing an additional 34 shares during the last quarter. 85.36% of the stock is owned by institutional investors and hedge funds.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) opened at 116.15 on Wednesday. Zimmer Biomet Holdings, Inc. has a 12 month low of $95.63 and a 12 month high of $133.49. The company has a market cap of $23.48 billion, a price-to-earnings ratio of 33.08 and a beta of 1.19. The company’s 50-day moving average is $114.58 and its 200 day moving average is $120.50.

Zimmer Biomet Holdings (NYSE:ZBH) last posted its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $2.10 by ($0.02). Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The firm had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.95 billion. During the same quarter in the previous year, the business posted $2.02 earnings per share. The firm’s quarterly revenue was up 1.1% compared to the same quarter last year. Equities analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.24 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 22nd will be paid a $0.24 dividend. This represents a $0.96 annualized dividend and a yield of 0.83%. The ex-dividend date of this dividend is Thursday, September 21st. Zimmer Biomet Holdings’s payout ratio is 27.59%.

In other Zimmer Biomet Holdings news, VP Tony W. Collins sold 16,986 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $121.74, for a total transaction of $2,067,875.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.07% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Dimensional Fund Advisors LP Grows Stake in Zimmer Biomet Holdings, Inc. (ZBH)” was originally reported by Marea Informative and is owned by of Marea Informative. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright law. The correct version of this piece can be viewed at http://www.mareainformativa.com/dimensional-fund-advisors-lp-grows-stake-in-zimmer-biomet-holdings-inc-zbh/115594/.

A number of equities analysts recently weighed in on the company. Royal Bank Of Canada reissued an “outperform” rating and issued a $140.00 price target on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Wells Fargo & Company reaffirmed a “market weight” rating on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Jefferies Group LLC reaffirmed a “buy” rating and set a $148.00 price objective on shares of Zimmer Biomet Holdings in a research note on Friday, June 30th. Piper Jaffray Companies reiterated a “buy” rating and issued a $135.00 target price on shares of Zimmer Biomet Holdings in a report on Friday, July 28th. Finally, Oppenheimer Holdings, Inc. set a $137.00 target price on shares of Zimmer Biomet Holdings and gave the stock a “buy” rating in a report on Friday, July 28th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $136.55.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Stock Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related stocks with our FREE daily email newsletter.